New cancer clinical trial: Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases
Published on: October 30, 2018 at 11:00PM
Condition: Neuroendocrine Tumors
Intervention: Drug: [90]Y-DOTATOC
Sponsors: Sandeep Laroia; National Institutes of Health (NIH); Holden Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting
https://ift.tt/2qimPm9 Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases
Condition: Neuroendocrine Tumors
Intervention: Drug: [90]Y-DOTATOC
Sponsors: Sandeep Laroia; National Institutes of Health (NIH); Holden Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting
https://ift.tt/2qimPm9 Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases
Comments
Post a Comment